Author: Ruan, Hao; Gao, Shaoyan; Li, Shuangling; Luan, Jiaoyan; Jiang, Qiuyan; Li, Xiaohe; Yin, Huijun; Zhou, Honggang; Yang, Cheng
Title: Deglycosylated Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1 Signaling Pathway Cord-id: imiexl1f Document date: 2021_5_10
ID: imiexl1f
Snippet: Idiopathic pulmonary fibrosis (IPF) is a progressive, life-threatening lung disease characterized by the proliferation of myofibroblasts and deposition of extracellular matrix that results in irreversible distortion of the lung structure and the formation of focal fibrosis. The molecular mechanism of IPF is not fully understood, and there is no satisfactory treatment. However, most studies suggest that abnormal activation of transforming growth factor-β1 (TGF-β1) can promote fibroblast activat
Document: Idiopathic pulmonary fibrosis (IPF) is a progressive, life-threatening lung disease characterized by the proliferation of myofibroblasts and deposition of extracellular matrix that results in irreversible distortion of the lung structure and the formation of focal fibrosis. The molecular mechanism of IPF is not fully understood, and there is no satisfactory treatment. However, most studies suggest that abnormal activation of transforming growth factor-β1 (TGF-β1) can promote fibroblast activation and epithelial to mesenchymal transition (EMT) to induce pulmonary fibrosis. Deglycosylated azithromycin (Deg-AZM) is a compound we previously obtained by removing glycosyls from azithromycin; it was demonstrated to exert little or no antibacterial effects. Here, we discovered a new function of Deg-AZM in pulmonary fibrosis. In vivo experiments showed that Deg-AZM could significantly reduce bleomycin-induced pulmonary fibrosis and restore respiratory function. Further study revealed the anti-inflammatory and antioxidant effects of Deg-AZM in vivo. In vitro experiments showed that Deg-AZM inhibited TGF-β1 signaling, weakened the activation and differentiation of lung fibroblasts, and inhibited TGF-β1-induced EMT in alveolar epithelial cells. In conclusion, our findings show that Deg-AZM exerts antifibrotic effects by inhibiting TGF-β1-induced myofibroblast activation and EMT.
Search related documents:
Co phrase search for related documents- absence presence and acute exacerbation: 1, 2
- absence presence and acute lung injury: 1, 2, 3
- absence presence and administration route: 1
- absence presence and loading control: 1, 2, 3
- absence presence and local microenvironment: 1
- absence presence and lung fibroblast: 1
- absence presence and lung injury: 1, 2, 3, 4
- absence presence and lung macrophage: 1
- absence presence and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8
- absence presence and lung total: 1, 2, 3
- absence presence and lymphocyte macrophage: 1
- absence presence and lymphocyte macrophage neutrophil: 1
- absence presence and lymphocyte macrophage neutrophil count: 1
- absence presence and lysis buffer: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date